Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Amylin Pharmaceuticals is a biopharmaceutical company committed to improving lives through the discovery, development and commercialization of innovative medicines. Amylin has developed and gained approval for two first- in-class medicines for diabetes, SYMLIN(R) (pramlintide acetate) injection and BYETTA(R) (exenatide) injection. Amylin’s research and development activities leverage the company’s expertise in metabolism to develop potential therapies to treat diabetes, obesity and cardiovascular disease. Amylin is located in San Diego, California with over 1250 employees nationwide. ( www.amylin.com )
Amylin Pharmaceuticals , Inc.
9360 Towne Centre Drive Suite 110
San Diego, California 92121
USA
Tel: (858) 552-2200
Fax: (858) 552-2212